Customized chemotherapy based on <it>epidermal growth factor receptor</it> mutation status for elderly patients with advanced non-small-cell lung cancer: a phase II trial

Customized chemotherapy based on <it>epidermal growth factor receptor</it> mutation status for elderly patients with advanced non-small-cell lung cancer: a phase II trial

<p>Abstract</p> <p>Background</p> <p>Elderly patients are more vulnerable to toxicity from chemotherapy. Activating <it>epidermal growth factor receptor</it> (<it>EGFR</it>) mutations in non-small-cell lung cancer (NSCLC) are associated with enha...

Full description

Bibliographic Details
Main Authors: Fujita Shiro, Katakami Nobuyuki, Masago Katsuhiro, Yoshioka Hiroshige, Tomii Keisuke, Kaneda Toshihiko, Hirabayashi Masataka, Kunimasa Kei, Morizane Toshio, Mio Tadashi
Format: Article
Language:English
Published: BMC 2012-05-01
Series:BMC Cancer
Online Access:http://www.biomedcentral.com/1471-2407/12/185

Internet

http://www.biomedcentral.com/1471-2407/12/185

Similar Items